Routine board and accounting officer appointments with no financial statement impact. Monitor for any future strategic shifts given Sayer's digital health background, but no immediate trading catalyst.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 4 $168.58entry
- T+1 · 12d ago −8.99%α −4.58% · $153.43
- T+5 · 6d ago −8.19%α −7.27% · $154.78
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Guardant Health appointed Kevin R. Sayer, former CEO and current Executive Chairman of Dexcom, to its board of directors and appointed Robert A. Parks as Chief Accounting Officer. Both appointments are routine governance changes with no material financial impact.
Key Facts
- Board expanded to 11 directors with appointment of Kevin R. Sayer, effective November 2, 2026
- Sayer is former CEO (2015-2026) and current Executive Chairman of Dexcom
- Sayer receives standard non-employee director compensation: $500,000 RSU initial award and $60,000 annual cash retainer
- Robert A. Parks appointed Chief Accounting Officer, effective November 2, 2026
- Parks previously served as CAO of Fortrea Holdings, SailPoint Technologies, NetApp, and Syneos Health
- No departures were reported; no red flags in appointment language
Financial Impact
Standard director compensation: $500,000 RSU plus $60,000 annual cash retainer; CAO compensation not specified in dollar terms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-445514 |
| Document: d173393dex991.htm | 0001193125-26-445514 |
| Document: 0001193125-26-445514-index-headers.html | 0001193125-26-445514 |
| Document: 0001193125-26-445514-index.html | 0001193125-26-445514 |
| Document: 0001193125-26-445514.txt | 0001193125-26-445514 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Viewing Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers